Primary |
Small Cell Lung Cancer Metastatic |
25.0% |
Multiple Myeloma |
18.8% |
Convulsion |
12.5% |
Pancreatic Carcinoma Metastatic |
12.5% |
Asthenia |
6.3% |
Neoplasm Malignant |
6.3% |
Small Cell Lung Cancer Stage Unspecified |
6.3% |
Drug Use For Unknown Indication |
3.1% |
Migraine |
3.1% |
Peroneal Muscular Atrophy |
3.1% |
Product Used For Unknown Indication |
3.1% |
|
Convulsion |
9.5% |
Death |
9.5% |
Pulmonary Embolism |
9.5% |
Renal Failure |
9.5% |
Agitation |
4.8% |
Cerebrovascular Accident |
4.8% |
Convulsive Threshold Lowered |
4.8% |
Drug Interaction |
4.8% |
Hyperglycaemia |
4.8% |
Palpitations |
4.8% |
Reaction To Drug Excipients |
4.8% |
Renal Tubular Necrosis |
4.8% |
Urinary Tract Infection |
4.8% |
Urine Output Decreased |
4.8% |
Vomiting |
4.8% |
Weight Increased |
4.8% |
White Blood Cell Disorder |
4.8% |
|
Secondary |
Drug Use For Unknown Indication |
26.9% |
Myelodysplastic Syndrome |
13.3% |
Product Used For Unknown Indication |
12.6% |
Acute Myeloid Leukaemia |
8.4% |
Sedation |
4.7% |
Multiple Myeloma |
4.6% |
Pharyngitis |
4.1% |
Prostate Cancer Metastatic |
4.0% |
Hypertension |
3.6% |
Antibiotic Therapy |
2.5% |
Antibiotic Level |
2.1% |
Vitamin Supplementation |
2.1% |
Nasopharyngitis |
1.9% |
Anaesthesia |
1.5% |
Bipolar Disorder |
1.4% |
Myelofibrosis |
1.4% |
Polyuria |
1.4% |
Intentional Overdose |
1.3% |
Muscle Relaxant Therapy |
1.1% |
Pain |
1.1% |
|
Toxic Epidermal Necrolysis |
13.2% |
Pyrexia |
11.3% |
Vomiting |
9.4% |
Anaphylactic Reaction |
5.7% |
Off Label Use |
5.7% |
Pneumonia |
5.7% |
Ulcerative Keratitis |
5.7% |
Cytolytic Hepatitis |
4.7% |
Tubulointerstitial Nephritis |
4.7% |
Cataract |
3.8% |
Renal Failure Acute |
3.8% |
Swollen Tongue |
3.8% |
Electrocardiogram Qt Prolonged |
2.8% |
Intentional Overdose |
2.8% |
Malaise |
2.8% |
Melaena |
2.8% |
Nasopharyngitis |
2.8% |
Pericardial Effusion |
2.8% |
Pneumothorax |
2.8% |
Pulmonary Valve Stenosis |
2.8% |
|
Concomitant |
Product Used For Unknown Indication |
29.6% |
Drug Use For Unknown Indication |
23.6% |
Hypertension |
5.6% |
Osteoporosis |
4.4% |
Pain |
4.1% |
Rheumatoid Arthritis |
4.0% |
Vitamin Supplementation |
3.8% |
Prophylaxis |
3.3% |
Depression |
2.4% |
Supplementation Therapy |
2.3% |
Blood Cholesterol Increased |
2.1% |
Gastrooesophageal Reflux Disease |
1.8% |
Contraception |
1.8% |
Osteopenia |
1.7% |
Medical Diet |
1.7% |
Crohn's Disease |
1.6% |
Diabetes Mellitus |
1.6% |
Asthma |
1.5% |
Multiple Sclerosis |
1.5% |
Anxiety |
1.4% |
|
Vomiting |
12.5% |
Weight Decreased |
9.5% |
Weight Increased |
6.7% |
Pain |
6.2% |
Flushing |
5.6% |
Urinary Tract Infection |
5.4% |
Pulmonary Embolism |
4.5% |
Nausea |
4.4% |
Pain In Extremity |
4.4% |
Pruritus |
4.4% |
Drug Ineffective |
4.2% |
Pneumonia |
4.2% |
Rash |
4.1% |
Dyspnoea |
3.8% |
Death |
3.7% |
Pyrexia |
3.5% |
White Blood Cell Count Decreased |
3.3% |
Headache |
3.3% |
Vision Blurred |
3.1% |
Urticaria |
2.9% |
|
Interacting |
Product Used For Unknown Indication |
41.8% |
Prophylaxis |
9.1% |
Systemic Candida |
7.3% |
Atrial Fibrillation |
3.6% |
Drug Use For Unknown Indication |
3.6% |
Headache |
3.6% |
Hypertension |
3.6% |
Lung Neoplasm Malignant |
3.6% |
Renal Failure Chronic |
3.6% |
Anal Candidiasis |
1.8% |
Anticoagulant Therapy |
1.8% |
Cough |
1.8% |
Iron Deficiency |
1.8% |
Ischaemic Heart Disease Prophylaxis |
1.8% |
Liver Transplant |
1.8% |
Lower Respiratory Tract Infection |
1.8% |
Pneumonia |
1.8% |
Thyroid Disorder |
1.8% |
Tremor |
1.8% |
Venous Thrombosis |
1.8% |
|
International Normalised Ratio Increased |
17.6% |
Drug Interaction |
11.8% |
Gastrointestinal Infection |
11.8% |
Haemorrhagic Diathesis |
11.8% |
Blood Creatinine Increased |
5.9% |
Cervical Incompetence |
5.9% |
Fatigue |
5.9% |
Inhibitory Drug Interaction |
5.9% |
Performance Status Decreased |
5.9% |
Prostatic Calcification |
5.9% |
Tremor |
5.9% |
Vomiting |
5.9% |
|